Research and Markets: Epiomic Epidemiology Series Report - Cerebral Palsy Forecast in 8 Major Markets 2015-2025

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mffgjn/epiomic) has announced the addition of the "Epiomic Epidemiology Series: Cerebral Palsy Forecast in 8 Major Markets 2015-2025" report to their offering.

Cerebral Palsy lacks a precise definition as it is not a single disease, but an umbrella term describing non-progressive brain lesions involving motor or postural abnormalities that are noted in early development. The exact pathological mechanisms and processes that cause Cerebral Palsy are largely unknown. However, premature birth, exposure to infection or radiation during pregnancy and post-natal head injuries are all associated risk factors in developing Cerebral Palsy.

This report provides the current prevalent population for Cerebral Palsy across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Cerebral Palsy have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Cerebral Palsy include:

- Low weight at birth

- Premature birth (pre-term)

- Epilepsy and seizures

- Sensory impairment

- Congenital malformations

Key Topics Covered:

1. List of Tables and Figures

2. Introduction

3. Cause of the Disease

- Risk Factors & Prevention

- Diagnosis of the Disease

- Variation by Geography/Ethnicity

- Disease Prognosis & Clinical Course

- Key Co-morbid Conditions /Features Associated with the Disease

4. Methodology for Quantification of Patient Numbers

- Top-Line Prevalence for Cerebral Palsy

5. Main Features of Cerebral Palsy

- Type of Motor Symptoms

- Cerebral Palsy by topographic type

- GMFCS Level in Cerebral Palsy Patients

- BFMF Level in Cerebral Palsy Patients

- Timing of onset of Cerebral Palsy

- Cause of post-natal Cerebral Palsy

- Gestational age at time of birth

- Walk ability in patients with Cerebral Palsy

- Neurological Comorbidites in Cerebral Palsy Patients

- Intellectual Deficit in Cerebral Palsy

- Sensory deficits in Cerebral Palsy Patients

- Orthopaedic Impairments

- Congenital malformations in patients with Cerebral Palsy

- Abbreviations and Acronyms used in the Report

6. References

For more information visit http://www.researchandmarkets.com/research/mffgjn/epiomic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals